| pubmed-article:20448468 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20448468 | lifeskim:mentions | umls-concept:C0043167 | lld:lifeskim |
| pubmed-article:20448468 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:20448468 | lifeskim:mentions | umls-concept:C0032374 | lld:lifeskim |
| pubmed-article:20448468 | lifeskim:mentions | umls-concept:C0718003 | lld:lifeskim |
| pubmed-article:20448468 | lifeskim:mentions | umls-concept:C0205341 | lld:lifeskim |
| pubmed-article:20448468 | lifeskim:mentions | umls-concept:C1613021 | lld:lifeskim |
| pubmed-article:20448468 | lifeskim:mentions | umls-concept:C0276240 | lld:lifeskim |
| pubmed-article:20448468 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:20448468 | pubmed:dateCreated | 2011-4-20 | lld:pubmed |
| pubmed-article:20448468 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20448468 | pubmed:abstractText | The rising incidence of pertussis amongst adults and adolescents in industrialized countries could be reduced by replacing tetanus and diphtheria (Td) boosters with reduced-antigen-content dT-acellular pertussis (dTpa)vaccines. Repeated administration of a dTpa-IPV (dTpa-inactivated poliomyelitis; BoostrixTM Polio, GlaxoSmithKline)booster to adolescents, 5 years after their previous dose was evaluated. | lld:pubmed |
| pubmed-article:20448468 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20448468 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20448468 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20448468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20448468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20448468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20448468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20448468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20448468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20448468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20448468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20448468 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20448468 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:20448468 | pubmed:issn | 1554-8619 | lld:pubmed |
| pubmed-article:20448468 | pubmed:author | pubmed-author:KnufMarkusM | lld:pubmed |
| pubmed-article:20448468 | pubmed:author | pubmed-author:GunasekaranRa... | lld:pubmed |
| pubmed-article:20448468 | pubmed:author | pubmed-author:Van Der... | lld:pubmed |
| pubmed-article:20448468 | pubmed:author | pubmed-author:VetterVolkerV | lld:pubmed |
| pubmed-article:20448468 | pubmed:author | pubmed-author:CelzoFroilanF | lld:pubmed |
| pubmed-article:20448468 | pubmed:author | pubmed-author:JacquetJeanne... | lld:pubmed |
| pubmed-article:20448468 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20448468 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:20448468 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20448468 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20448468 | pubmed:pagination | 554-61 | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:meshHeading | pubmed-meshheading:20448468... | lld:pubmed |
| pubmed-article:20448468 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20448468 | pubmed:articleTitle | Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV). | lld:pubmed |
| pubmed-article:20448468 | pubmed:affiliation | Zentrum fur Kinder-und Jugendmedizin, Universitatsmedizin, Rheinland-Pfalz, Germany. | lld:pubmed |
| pubmed-article:20448468 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20448468 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:20448468 | pubmed:publicationType | Clinical Trial, Phase IV | lld:pubmed |
